2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-5-hydroxy-3,4,5-trimethyl-,(3R,4S,5R,13aR,13bR)- (9CI) (120154-95-2)

Identification
Name:	2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-5-hydroxy-3,4,5-trimethyl-,(3R,4S,5R,13aR,13bR)- (9CI)
Synonyms:	20-Norcrotalanan-11,15-dione,14,19-dihydro-12-hydroxy-, (13a,14a)-; (-)-Crotaleschenine;1,2-Didehydroretusine;2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-5-hydroxy-3,4,5-trimethyl-,[3R-(3R,4S,5R,13aR,13bR*)]-; Crotaleschenine
CAS:	120154-95-2
Molecular Formula:	C16H23 N O5
Molecular Structure:
Properties
Safety Data

Other Product

(3R,4R,5R,13aR,13bR)-4,5-dihydroxy-5-[(1R)-1-hydroxyethyl]-3-(propan-2-yl)-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,5-ethyl-4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3-(1-methylethyl)-,(3R,4R,5R,13aR,13bR)- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-4-hydroxy-3,4,5-trimethyl-,(3R,4S,5S,13aR,13bR)- (9CI)
Butanoic acid,2-methyl-,(3R,4S,5R,13aR,13bR)-3,4,5,6,8,10,12,13,13a,13b-decahydro-5-hydroxy-3,4,5-trimethyl-2,6-dioxo-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizin-4-ylester, (2R)- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,5-ethyl-4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3-(1-methylethyl)-,(5R,13aR,13bR)- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine- 2,6(3H)-dione,4,5,8,10,12,13,13a,13boctahydro- 4,5-dihydroxy-5-(hydroxymethyl)- 4-methyl-3-(1-methylethyl)-,(3R,4R,5R,- 13aR,13bR)-
(3R,4S,5R,8aR,13aR,13bR)-5-hydroxy-3,4,5-trimethyldecahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
(3R,4R,5R,13aR,13bR)-4,5-dihydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione hydrochloride (1:1)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,decahydro-4-hydroxy-3,4,5-trimethyl-, (8aR,13aR,13bR)- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3,4,5-trimethyl-,(3R,4R,5R,13aR,13bR)-
8H,11H-Oxeto[2',3':9,10][1,6]dioxacycloundecino- [2,3,4-gh]pyrrolizine-8,12(9H)-dione,1,2,4,6,- 9a,11a,13a,13b-octahydro-,(9R,9aR,11aR,- 13aR,13bR)-
4-hydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
4,5-dihydroxy-5-methyl-3-(propan-2-yl)-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
(13aR,13bR)-4,4-dimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
4-hydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione 11-oxide
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizinium,3,4,5,6,8,10,12,13,13a,13b-decahydro-5,13b-dihydroxy-4,5,11-trimethyl-3-(1-methylethyl)-2,6-dioxo-,(3R,4S,5R,11R,13aR,13bS)- (9CI)
5-(1-hydroxyethyl)-3,4-dimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,12,13,13a-hexahydro-4,5-dihydroxy-3,4,5-trimethyl-, (3R,4R,5R,13aR)-
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine- 2,6(3H)-dione,4,5,8,10,12,13,13a,13boctahydro- 4-hydroxy-3,4,5-trimethyl-
2(3H)-Furanone,3-[(3S,6aS,6bR,8aS,9S,11aS,- 11bR,12R,13aR,13bR)-3,4,6,6a,6b,10,11,11b,12,- 13,13a,13b-dodecahydro-12-hydroxy-6a,11b,- 13b-trimethyl-3-phenyl-1H,9H-8a,11amethanocyclopenta[ 7,8]phenanthro[1,2-c]pyran- 9-yl]dihydro-5-[(1E)-3-hydroxy-2-methyl- 1-propenyl]-,(3S,5R)-